21 results on '"Stephan Culemann"'
Search Results
2. Adopted orphans as regulators of inflammation, immunity and skeletal homeostasis
- Author
-
Natacha Ipseiz, Carina Scholtysek, Stephan Culemann, and Gerhard Krönke
- Subjects
inflammation ,bone ,Arthritis ,nuclear receptors ,Macrophages ,Osteoblasts ,Medicine - Abstract
Adopted orphan nuclear receptors, such as peroxisome proliferator-activated receptors (PPARs) and liver X receptors (LXRs), have emerged as key regulators of inflammation and immunity and likewise control skeletal homeostasis. These properties render them attractive targets for the therapy of various inflammatory and autoimmune diseases affecting the musculoskeletal system. This review summarises the current knowledge on the role of these families of receptors during innate and adaptive immunity as well as during the control of bone turnover and discuss the potential use of targeting these molecules during the treatment of chronic diseases such as osteoarthritis, rheumatoid arthritis and osteoporosis.
- Published
- 2014
- Full Text
- View/download PDF
3. Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes
- Author
-
Stephan Culemann, Katharina Knab, Maximilien Euler, Anja Wegner, Hilal Garibagaoglu, Jochen Ackermann, Kim Fischer, Deborah Kienhöfer, Georgiana Crainiciuc, Jonas Hahn, Anika Grüneboom, Falk Nimmerjahn, Stefan Uderhardt, Andrés Hidalgo, Georg Schett, Markus H. Hoffmann, and Gerhard Krönke
- Subjects
Immunology ,Immunology and Allergy - Abstract
Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.
- Published
- 2023
4. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis
- Author
-
Udo S. Gaipl, Vugar Azizov, Benjamin Frey, Mario M. Zaiss, Francesco Ciccia, Klaus Überla, Michael Frech, Kerstin Sarter, Aroldo Rizzo, Arnd Kleyer, Marko Bertog, Yubin Luo, Georg Schett, Kerstin Dürholz, Yasunori Omata, Andreas Rings, Franziska Steffen, Oscar Schulz, Marijana Basic, Gerhard Krönke, Stephan Culemann, Till Strowig, Fabian Schälter, Stephan C. Bischoff, Narges Tajik, Juan D. Cañete, Stefan Wirtz, Sébastien Lucas, Aida Iljazovic, Tajik, N., Frech, M., Schulz, O., Schalter, F., Lucas, S., Azizov, V., Durholz, K., Steffen, F., Omata, Y., Rings, A., Bertog, M., Rizzo, A., Iljazovic, A., Basic, M., Kleyer, A., Culemann, S., Kronke, G., Luo, Y., Uberla, K., Gaipl, U. S., Frey, B., Strowig, T., Sarter, K., Bischoff, S. C., Wirtz, S., Canete, J. D., Ciccia, F., Schett, G., and Zaiss, M. M.
- Subjects
0301 basic medicine ,Male ,Cell Membrane Permeability ,Inflammatory arthritis ,General Physics and Astronomy ,Arthritis ,Autoimmunity ,medicine.disease_cause ,Arthritis, Rheumatoid ,Cohort Studies ,Mice ,0302 clinical medicine ,Intestinal Mucosa ,lcsh:Science ,Barrier function ,Multidisciplinary ,Zonulin ,food and beverages ,Middle Aged ,Healthy Volunteers ,3. Good health ,Female ,medicine.symptom ,Oligopeptides ,Adult ,Cholera Toxin ,Science ,Inflammation ,General Biochemistry, Genetics and Molecular Biology ,Article ,Tight Junctions ,03 medical and health sciences ,Ileum ,medicine ,Animals ,Humans ,Rheumatoid arthritis ,Protein Precursors ,030203 arthritis & rheumatology ,Autoimmune disease ,Haptoglobins ,business.industry ,fungi ,General Chemistry ,medicine.disease ,Arthritis, Experimental ,Gastrointestinal Microbiome ,030104 developmental biology ,Cross-Sectional Studies ,Bacterial Translocation ,Immunology ,Dysbiosis ,lcsh:Q ,Caco-2 Cells ,business - Abstract
Gut microbial dysbiosis is associated with the development of autoimmune disease, but the mechanisms by which microbial dysbiosis affects the transition from asymptomatic autoimmunity to inflammatory disease are incompletely characterized. Here, we identify intestinal barrier integrity as an important checkpoint in translating autoimmunity to inflammation. Zonulin family peptide (zonulin), a potent regulator for intestinal tight junctions, is highly expressed in autoimmune mice and humans and can be used to predict transition from autoimmunity to inflammatory arthritis. Increased serum zonulin levels are accompanied by a leaky intestinal barrier, dysbiosis and inflammation. Restoration of the intestinal barrier in the pre-phase of arthritis using butyrate or a cannabinoid type 1 receptor agonist inhibits the development of arthritis. Moreover, treatment with the zonulin antagonist larazotide acetate, which specifically increases intestinal barrier integrity, effectively reduces arthritis onset. These data identify a preventive approach for the onset of autoimmune disease by specifically targeting impaired intestinal barrier function., Intestinal dysbiosis is associated with an ever-growing list of autoimmune diseases. Here the authors show that both mice and humans with autoimmune arthritis can have dysbiosis and barrier leakiness prior to major signs of inflammatory arthritis, and treatment of mice with a zonulin antagonist can limit collagen-induced arthritis.
- Published
- 2020
5. Novel Insights into the Ontogenetic and Functional Heterogeneity of Macrophages in Synovial Tissue and Bone
- Author
-
Claudia Waskow, Gulce Itir Percin, Anika Grüneboom, and Stephan Culemann
- Subjects
Genetically modified mouse ,Innate immune system ,Medizin ,Arthritis ,General Medicine ,Biology ,medicine.disease ,Bone resorption ,Proinflammatory cytokine ,Immune system ,Single-cell analysis ,Rheumatoid arthritis ,Immunology ,medicine - Abstract
Inflammatory joint diseases like rheumatoid arthritis (RA) belong to the most prevalent autoimmune disorders. RA is characterized by a massive infiltration of immune cells into synovial tissue, cartilage destruction and bone erosion. The perpetuating inflammatory and destructive milieu is associated with severe pain and culminates in complete disability of synovial joints. The events initiating RA are still not fully understood and the treatments are mainly confined to strategies that modify and inhibit the body’s immune system. Macrophages and osteoclasts (OC) are myeloid cells of the innate immune system and are considered to play a central role in the inflammatory and destructive events of arthritis by production of inflammatory cytokines and mediating pathological bone resorption. In recent years, the use of novel fate mapping strategies identifying the origin and cellular development (ontogeny) of OC and macrophages in conjunction with new genetically modified mouse models, single cell analysis and advanced imaging techniques substantially changed our understanding on the ontogenetic and functional heterogeneity of these cells.
- Published
- 2021
6. The glucocorticoid receptor (GR) orchestrates the crosstalk between fibroblast-like synoviocytes and macrophages to reduce Inflammation in arthritis
- Author
-
Giorgio Caratti, U Baschant, U. auf dem Keller, Jan Tuckermann, G Krönke, Mascha Koenen, Stephan Culemann, W Baum, Sabine Vettorazzi, K Paxian, and Lucien Frappart
- Subjects
Crosstalk (biology) ,Glucocorticoid receptor ,medicine.anatomical_structure ,Chemistry ,medicine ,Cancer research ,Arthritis ,Inflammation ,medicine.symptom ,Fibroblast ,medicine.disease - Published
- 2019
7. Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis
- Author
-
Wolfgang Baum, Gerhard Krönke, Mascha Koenen, Jan Tuckermann, Sabine Vettorazzi, Giorgio Caratti, Lucien Frappart, Stephan Culemann, and Ulrike Baschant
- Subjects
0301 basic medicine ,Inflammatory arthritis ,Antiphlogistikum ,Arthritis ,Dexamethasone ,corticosteroids ,Arthritis, Rheumatoid ,DDC 570 / Life sciences ,0302 clinical medicine ,Glucocorticoid receptor ,Immunology and Allergy ,Basic and Translational Research ,Macrophage inflammatory protein ,Mice, Inbred BALB C ,Immune cells ,Synoviocytes ,arthritis ,Cytokines ,medicine.symptom ,Dimerization ,Anti-inflammatory mechanism ,Immunocompetence ,Glucocorticoid ,medicine.drug ,Stromal cell ,Glucocorticoid therapy ,Immunology ,Glucocorticoids ,Therapeutic use ,Inflammation ,Anti-Inflammatory agents ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Receptors, Glucocorticoid ,Immune system ,Rheumatology ,fibroblasts ,ddc:570 ,medicine ,Animals ,Humans ,Immunozyt ,ddc:610 ,Glucocorticosteroide ,Transplantation Chimera ,business.industry ,medicine.disease ,Arthritis, Experimental ,Mice, Inbred C57BL ,030104 developmental biology ,Gene Expression Regulation ,Cancer research ,Stromal Cells ,business ,DDC 610 / Medicine & health ,Metabolism, Inborn Errors ,030215 immunology - Abstract
Background Glucocorticoid (GC) therapy is frequently used to treat rheumatoid arthritis due to potent anti-inflammatory actions of GCs. Direct actions of GCs on immune cells were suggested to suppress inflammation. Objectives Define the role of the glucocorticoid receptor (GR) in stromal cells for suppression of inflammatory arthritis. Methods Bone marrow chimeric mice lacking the GR in the hematopoietic or stromal compartment, respectively, and mice with impaired GR dimerisation (GRdim) were analysed for their response to dexamethasone (DEX, 1 mg/kg) treatment in serum transfer-induced arthritis (STIA). Joint swelling, cell infiltration (histology), cytokines, cell composition (flow cytometry) and gene expression were analysed and RNASeq of wild type and GRdim primary murine fibroblast-like synoviocytes (FLS) was performed. Results GR deficiency in immune cells did not impair GC-mediated suppression of STIA. In contrast, mice with GR-deficient or GR dimerisation-impaired stromal cells were resistant to GC treatment, despite efficient suppression of cytokines. Intriguingly, in mice with impaired GR function in the stromal compartment, GCs failed to stimulate non-classical, non-activated macrophages (Ly6Cneg, MHCIIneg) and associated anti-inflammatory markers CD163, CD36, AnxA1, MerTK and Axl. Mice with GR deficiency in FLS were partially resistant to GC-induced suppression of STIA. Accordingly, RNASeq analysis of DEX-treated GRdim FLS revealed a distinct gene signature indicating enhanced activity and a failure to reduce macrophage inflammatory protein (Mip)-1α and Mip-1β. Conclusion We report a novel anti-inflammatory mechanism of GC action that involves GR dimerisation-dependent gene regulation in non-immune stromal cells, presumably FLS. FLS control non-classical, anti-inflammatory polarisation of macrophages that contributes to suppression of inflammation in arthritis., publishedVersion
- Published
- 2018
8. Eosinophils are not essential for maintenance of murine plasma cells in the bone marrow
- Author
-
Stephan Culemann, Jochen A. Ackermann, Natacha Ipseiz, Georg Schett, Hans-Martin Jäck, Katharina Pracht, Gerhard Krönke, Konrad Haberland, Wolfgang Schuh, and Matthias Englbrecht
- Subjects
0301 basic medicine ,Plasma Cells ,Immunology ,Bone Marrow Cells ,Mice, Transgenic ,Disease ,Biology ,Plasma cell ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Bone Marrow ,medicine ,Animals ,Lupus Erythematosus, Systemic ,Immunology and Allergy ,Autoantibodies ,Autoimmune disease ,Mice, Inbred BALB C ,Wild type ,GATA1 ,medicine.disease ,Eosinophils ,Disease Models, Animal ,030104 developmental biology ,medicine.anatomical_structure ,Antibody Formation ,Humoral immunity ,biology.protein ,Bone marrow ,Antibody ,030215 immunology - Abstract
Eosinophils were reported to serve as an essential component of the plasma cell niche within the bone marrow. As the potential contribution of eosinophils to humoral immunity has remained incompletely understood, we aimed to further characterize their role during antibody responses and to additionally investigate their role in autoimmune disease. Contrary to our expectations and the currently prevailing paradigm, we found that eosinophils are fully dispensable for the survival of murine bone marrow plasma cells and accordingly do not contribute to antibody production and autoantibody-mediated disease. Littermate wild type and eosinophil-deficient ΔdblGATA-1 animals showed similar numbers and frequencies of plasma cells and did not differ in steady state levels of immunoglobulins or their ability to raise antigen-specific antibody responses. Eosinophils were likewise dispensable for autoantibody production or autoantibody-induced disease in a mouse model of systemic lupus erythematosus. Our findings thus argue against a role of eosinophils during the maintenance of the plasma cell pool and challenge the hitherto postulated concept of an eosinophil-sustained bone marrow niche.
- Published
- 2018
9. A network of trans-cortical capillaries as mainstay for blood circulation in long bones
- Author
-
Alexandra Ohs, Daniel R. Engel, Wolfgang Baum, Stefan Landgraeber, Astrid M. Westendorf, Oliver Kraff, Alexandra Brenzel, Gerhard Krönke, Lasse Kling, Jens V. Stein, Alexandra Adamczyk, Marcel Dudda, Thomas Kamradt, Manfred Rohde, Matthias Gunzer, Stefanie C. Lang, Daniela Weidner, Daniel Hoffmann, Georg Schett, Anja Hasenberg, Silke Christiansen, Martin Herrmann, Ibrahim Hawwari, Sylvia Müller, Sylvia Voortmann, Stephan Culemann, Renzo Danuser, Andrea Vortkamp, Annette I. Garbe, Anika Grüneboom, Sophie Henneberg, Simon F. Merz, Marcus Jäger, Kristina Zec, Harald H. Quick, Lea Bornemann, Manuela Wuelling, Kolja Gelse, Mike Hasenberg, and HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
- Subjects
Pathology ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Medizin ,Inflammation ,Biology ,Bone and Bones ,Article ,Microcirculation ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Immune system ,Osteoclast ,Bone Marrow ,Physiology (medical) ,Internal Medicine ,medicine ,Animals ,Humans ,030304 developmental biology ,0303 health sciences ,Cell Biology ,Venous blood ,Capillaries ,medicine.anatomical_structure ,Mice, Inbred DBA ,Regional Blood Flow ,030220 oncology & carcinogenesis ,Circulatory system ,Cortical bone ,Bone marrow ,medicine.symptom - Abstract
Closed circulatory systems underlie the function of vertebrate organs, but in long bones their structure is unclear although they constitute the exit route for bone marrow (BM) leukocytes. To understand neutrophil migration from BM, we studied the vascular system of murine long bones. Here, in a mouse model, we show that hundreds of capillaries originate in BM, traverse cortical bone perpendicularly along the shaft and connect to the periosteal circulation. Structures similar to these trans-cortical vessels (TCVs) also exist in human limb bones. TCVs express arterial or venous markers and transport neutrophils. Furthermore, over 80% of arterial and 59% of venous blood passes through TCVs. Genetic and drug-mediated modulation of osteoclast count and activity leads to substantial changes in TCV numbers. In a murine model of chronic arthritic bone inflammation, new TCVs develop within weeks. Our data indicate that TCVs are a central component of the closed circulatory system in long bones and may represent an important route for immune cell export from BM.
- Published
- 2019
10. Origin and function of synovial macrophage subsets during inflammatory joint disease
- Author
-
Stephan, Culemann, Anika, Grüneboom, and Gerhard, Krönke
- Subjects
Arthritis, Rheumatoid ,Cellular Microenvironment ,Macrophages ,Synovial Fluid ,Animals ,Cytokines ,Humans ,Immunity, Innate ,Joint Capsule ,Monocytes ,Autoimmune Diseases - Abstract
Mononuclear phagocytes, including monocytes and macrophages, are a central component of the host's innate immune system designated to protect against invading pathogens. However, these cells do not only interact with various parts of the innate and adaptive immune system, but also fulfill indispensable duties during the control of tissue homeostasis and organ function. Moreover, macrophages are crucially involved in tissue remodeling and repair in response to damage. Simultaneously, mononuclear phagocytes might also contribute to the pathogenesis of various inflammatory and autoimmune diseases. In particular, their potential role in inflammatory joint diseases such as rheumatoid arthritis (RA) has drawn increasing attention and substantially shaped our general understanding of the role of monocytes and macrophages during health and disease. This review summarizes our current knowledge about the origin and function of mononuclear phagocytes within the joint and addresses their involvement in joint inflammation.
- Published
- 2019
11. OP0076 JAK-INHIBITORS TOFACITINIB AND BARICITINIB IMPROVE PATHOLOGICAL BONE LOSS IN VIVO
- Author
-
Carina Scholtysek, Ulrike Steffen, Georg Schett, Madelaine Hahn, Susanne Adam, Fabian T. Andes, Silke Frey, Stephan Culemann, Gerhard Krönke, Nils Simon, Axel J. Hueber, Née Harre, Darja Andreev, and Dorothea I. H. Müller
- Subjects
medicine.medical_specialty ,Tofacitinib ,biology ,Bone density ,business.industry ,Arthritis ,Osteoblast ,medicine.disease ,Blood serum ,medicine.anatomical_structure ,Endocrinology ,RANKL ,Osteoclast ,Internal medicine ,medicine ,biology.protein ,business ,Janus kinase - Abstract
Background Targeting cytokines relevant to rheumatoid arthritis (RA) has proven efficient in clinical practice, but there is still demand for therapies that rebuild joint tissues which have been subjected to deterioration. Since many cytokines involved in RA rely on the intracellular janus kinase - signal transducer and activator of transcription (JAK-STAT) signaling pathway, targeting them presents itself as option. For this approach, JAK-inhibitors such as Tofacitinib and Baricitinib, targeting JAK1/JAK3 and JAK1/JAK2 respectively, seem favorable, as they have been approved for the treatment of RA1. Moreover, preliminary data indicates an impact of JAK inhibition on local bone formation. Objectives To investigate the influence of JAK-inhibition on structural bone damage in vivo and its impact on osteoclast/osteoblast-mediated bone homeostasis in vitro. Methods In vivo analysis comprised unchallenged steady-state, the ovariectomy-induced mouse model of postmenopausal osteoporosis (OVX) and the serum-induced arthritis (SIA) mouse model. For steady-state analysis C57BL/6 (WT) mice obtained tofacitinib QD by oral gavage for 6 weeks. For OVX, WT mice received tofacitinib BID by oral gavage for 6 weeks. WT mice of the SIA model were fed tofacitinib or baricitinib BID for 14 days. Experimental readout included clinical parameters, ELISA (RANKL/OPG levels in serum), qPCR (mRNA expression in bone) and µCT. For in vitro analysis, murine osteoclasts (OC) were analyzed with TRAP staining (osteoclastogenesis) and von Kossa staining (Resorptive capacity). Murine osteoblasts (OB), derived from mesenchymal stem cells (MSC) and calvariae were assessed with qPCR (differentiation) and Alizarin red staining (mineralization capacity). Results In steady-state conditions, JAK-inhibition by tofacitinib enhanced tibial trabecular bone density and decreased RANKL/OPG fraction in blood serum. These findings, and increased trabeculae numbers, were also applicable to spinal bone of tofacitinib-treated OVX mice. In SIA, both baricitinib and tofacitinib improved clinical symptoms and halted trabecular and cortical bone loss. In vitro OC-differentiation and function were not affected by JAK-inhibition. However, tofacitinib and baricitinib amplified OCN expression in MSC-derived OBs at day 1 after osteogenic induction, together with reduced Igf1 and elevated Dkk1 levels at day 7. Moreover, as a result of JAK-inhibition RANKL expression was decreased in calvaria-derived OBs. Accordingly, both MSC- and calvaria-derived OBs showed increased mineralization when treated with JAK-inhibitors. Conclusion Our results suggest that JAK-inhibition by tofacitinib and baricitinib causes increased mineralization by osteoblasts, resulting in enhanced bone density in vivo, in both unchallenged and pathological mouse models. Reference [1] Baker KF, Isaacs JD, ARD, 2018 Acknowledgement Work funded by Pfizer, Eli Lilly. The MSC were a kind gift from Farida Djouad (IRMB, Centre Hospitalier Regional Universitaire de Montpellier). Susanne Adam is graduate member of IRTG1181 and Lifa@FAU. Disclosure of Interests Susanne Adam: None declared, Nils Simon: None declared, Ulrike Steffen (nee Harre): None declared, Fabian Andes: None declared, Dorothea Muller: None declared, Stephan Culemann: None declared, Darja Andreev: None declared, Madelaine Hahn: None declared, Carina Scholtysek: None declared, Georg Schett: None declared, Gerhard Kronke Grant/research support from: Lilly, Pfizer, Speakers bureau: Novartis, Silke Frey: None declared, Axel Hueber Grant/research support from: Novartis, Pfizer, Lilly, Consultant for: Lilly, GSK, Novartis, Janssen, Celgene, Abbvie, Roche, Speakers bureau: Lilly, Janssen, Novartis, Celgene, Biogen, Abbvie, BMS
- Published
- 2019
12. P148 JAK-inhibition by baricitinib and tofacitinib ameliorates pathological bone loss
- Author
-
Fabian T. Andes, Madelaine Hahn, Nils Simon, Stephan Culemann, Axel J. Hueber, Silke Frey, Susanne Adam, Dorothea I. H. Müller, Gerhard Krönke, Ulrike Steffen, Darja Andreev, Carina Scholtysek, and Georg Schett
- Subjects
030203 arthritis & rheumatology ,0301 basic medicine ,medicine.medical_specialty ,Tofacitinib ,biology ,business.industry ,Osteoporosis ,Arthritis ,Osteoblast ,Bone healing ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,Endocrinology ,RANKL ,Rheumatoid arthritis ,Internal medicine ,medicine ,biology.protein ,business ,Janus kinase - Abstract
Career situation of first and presenting author Student for a master or a PhD. Introduction Many cytokines relevant to rheumatoid arthritis (RA) rely on the janus kinase – signal transducer and activator of transcription (JAK-STAT) signaling pathway. The JAK-inhibitors tofacitinib and baricitinib, targeting JAK3/JAK1 and JAK1/JAK2 respectively, have been approved for treatment of RA1. While currently available therapies reduce inflammation, erosive damage in involved joints is still irreversible. However, preliminary data suggests an influence of JAK inhibition on local bone healing. Objectives To study the role of JAK-inhibition in osteoblast and osteoclast-mediated bone homeostasis and its capacity to alleviate structural bone damage in vivo. Methods For steady state analysis C57BL/6 (WT) mice received tofacitinib QD by oral gavage for 6 weeks. WT mice of the ovariectomy-induced osteoporosis model (OVX) obtained tofacitinib BID by oral gavage for 6 weeks. For the serum-induced arthritis model (SIA) WT mice received tofacitinib or baricitinib BID by oral gavage for 14 days. Readout covered serum cytokine levels (ELISA), µCT and mRNA analysis of bone (qPCR) and clinical scoring. Murine osteoclasts (OC) were assessed for differentiation (TRAP staining) and resorption (Von Kossa staining). Murine mesenchymal stem cell (MSC)-derived and primary osteoblasts (OB) were analyzed for differentiation (qPCR) and function (Alizarin red staining). Results In unchallenged WT mice, treatment with tofacitinib increased trabecular bone density in tibia and reduced RANKL/OPG ratio in serum. These results, along with elevated trabeculae numbers, also applied to spinal bone in tofacitinib-treated OVX mice. In SIA, baricitinib and tofacitinib ameliorated disease manifestation and inhibited trabecular/cortical bone loss. In vitro JAK-inhibition exhibited no effect on differentiation and function of OCs. However, it enhanced OCN expression in MSC-derived OBs at day 1 after osteoblastic induction and led to decreased Igf1 and increased Dkk1 expression at day 7. Accordingly, primary OBs showed reduced RANKL expression during JAK-inhibition. Moreover, both MSC- and primary OBs responded to JAK-inhibition with increased mineralization. Conclusions Our findings indicate that JAK-inhibition by tofacitinib and baricitinib increases bone formation in vivo, in both steady-state and pathological conditions, presumably as a result of increased mineralization capacity by osteoblasts. Reference Baker KF, Isaacs JD. ARD 2018. Acknowledgements Work funded by Pfizer and Eli Lilly. Disclosure of Interest S. Adam Grant/research support from: Pfizer, Eli Lilly, N. Simon: None declared, U. Steffen: None declared, F. Andes: None declared, D. Muller: None declared, S. Culemann: None declared, D. Andreev: None declared, M. Hahn: None declared, C. Scholtysek: None declared, G. Schett: None declared, G. Kronke: None declared, S. Frey: None declared, A. Hueber: None declared.
- Published
- 2019
13. Origin and function of synovial macrophage subsets during inflammatory joint disease
- Author
-
Anika Grüneboom, Stephan Culemann, and Gerhard Krönke
- Subjects
Pathogenesis ,Innate immune system ,Rheumatoid arthritis ,Immunology ,medicine ,Macrophage ,Inflammation ,Disease ,medicine.symptom ,Biology ,medicine.disease ,Acquired immune system ,Tissue homeostasis - Abstract
Mononuclear phagocytes, including monocytes and macrophages, are a central component of the host's innate immune system designated to protect against invading pathogens. However, these cells do not only interact with various parts of the innate and adaptive immune system, but also fulfill indispensable duties during the control of tissue homeostasis and organ function. Moreover, macrophages are crucially involved in tissue remodeling and repair in response to damage. Simultaneously, mononuclear phagocytes might also contribute to the pathogenesis of various inflammatory and autoimmune diseases. In particular, their potential role in inflammatory joint diseases such as rheumatoid arthritis (RA) has drawn increasing attention and substantially shaped our general understanding of the role of monocytes and macrophages during health and disease. This review summarizes our current knowledge about the origin and function of mononuclear phagocytes within the joint and addresses their involvement in joint inflammation.
- Published
- 2019
14. Locally renewing resident synovial macrophages provide a protective barrier for the joint
- Author
-
José Ángel Nicolás-Ávila, Tobias Bäuerle, Nina Renner, Milena L Pachowsky, Daniela Weidner, Anika Grüneboom, Jochen A. Ackermann, Fulvia Ferrazzi, Friedrich Paulsen, R Pfeifle, Stephan Culemann, Reiner F. Haseloff, Ingolf E. Blasig, Gerhard Krönke, Andrés Hidalgo, Katrin Franziska Lämmle, Juan A. Quintana, Arif B. Ekici, Tobias Rothe, Kim Fischer, Kolja Gelse, Philipp Kirchner, Martin Schicht, Arnd Kleyer, Elke Kretzschmar, David Voehringer, Georg Schett, Maria Faas, David Simon, Martin Eberhardt, Branislav Krljanac, and Julio Vera
- Subjects
0301 basic medicine ,Male ,Population ,CX3C Chemokine Receptor 1 ,Arthritis ,Inflammation ,Biology ,Peripheral blood mononuclear cell ,Article ,Tight Junctions ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Immune system ,CX3CR1 ,medicine ,Macrophage ,Animals ,Humans ,RNA-Seq ,education ,education.field_of_study ,Principal Component Analysis ,Multidisciplinary ,Innate immune system ,Gene Expression Profiling ,Macrophages ,Synovial Membrane ,medicine.disease ,Synoviocytes ,Cell biology ,Mice, Inbred C57BL ,030104 developmental biology ,Cell Tracking ,Female ,Joints ,medicine.symptom ,Single-Cell Analysis ,Transcriptome ,030215 immunology - Abstract
Macrophages are considered to contribute to chronic inflammatory diseases such as rheumatoid arthritis1. However, both the exact origin and the role of macrophages in inflammatory joint disease remain unclear. Here we use fate-mapping approaches in conjunction with three-dimensional light-sheet fluorescence microscopy and single-cell RNA sequencing to perform a comprehensive spatiotemporal analysis of the composition, origin and differentiation of subsets of macrophages within healthy and inflamed joints, and study the roles of these macrophages during arthritis. We find that dynamic membrane-like structures, consisting of a distinct population of CX3CR1+ tissue-resident macrophages, form an internal immunological barrier at the synovial lining and physically seclude the joint. These barrier-forming macrophages display features that are otherwise typical of epithelial cells, and maintain their numbers through a pool of locally proliferating CX3CR1− mononuclear cells that are embedded into the synovial tissue. Unlike recruited monocyte-derived macrophages, which actively contribute to joint inflammation, these epithelial-like CX3CR1+ lining macrophages restrict the inflammatory reaction by providing a tight-junction-mediated shield for intra-articular structures. Our data reveal an unexpected functional diversification among synovial macrophages and have important implications for the general role of macrophages in health and disease. Analysis of macrophage subsets within joints reveals a population of CX3CR1+ tissue-resident macrophages that form a tight-junction-mediated barrier at the synovial lining, protecting the joint from the invasion of inflammatory cells.
- Published
- 2019
- Full Text
- View/download PDF
15. A blast without power – cell death induced by the tuberculosis-necrotizing toxin fails to elicit adequate immune responses
- Author
-
Ricardo A. Chaurio, Maxim D. Lootsik, Malgorzata J. Podolska, Christoph Alexiou, Christian Berens, Christian Maueröder, Ralf P Friedrich, Luis E. Muñoz, Rostyslav Bilyy, Georg Schett, Martin Herrmann, Tetiana Dumych, and Stephan Culemann
- Subjects
0301 basic medicine ,Interleukin-27 ,Programmed cell death ,Ultraviolet Rays ,Melanoma, Experimental ,Apoptosis ,Caspase 3 ,Biology ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Cell Line, Tumor ,medicine ,Alarmins ,Animals ,Transplantation, Homologous ,HMGB1 Protein ,Molecular Biology ,Toxins, Biological ,Mice, Inbred BALB C ,Original Paper ,Cell growth ,Macrophages ,Immunogenicity ,Neurodegeneration ,Cell Biology ,medicine.disease ,Cell biology ,Mice, Inbred C57BL ,030104 developmental biology ,Cell culture ,Doxycycline ,030220 oncology & carcinogenesis ,Cytokines ,Reactive Oxygen Species ,Spleen ,BH3 Interacting Domain Death Agonist Protein - Abstract
In this study, we deploy a doxycycline-dependent suicide switch integrated in a tumor challenge model. With this experimental setup, we characterized the immunological consequences of cells dying by four distinct cell death stimuli in vivo. We observed that apoptotic cell death induced by expression of the truncated form of BH3 interacting-domain death agonist (tBid) and a constitutively active form of caspase 3 (revC3), respectively, showed higher immunogenicity than cell death induced by expression of the tuberculosis-necrotizing toxin (TNT). Our data indicate that the early release of ATP induces the silent clearance of dying cells, whereas the simultaneous presence of ‘find me' signals and danger-associated molecular patterns (DAMPs) promotes inflammatory reactions and increased immunogenicity. This proposed model is supported by findings showing that the production and release of high concentrations of IL-27 by bone-marrow-derived macrophages (BMDM) is limited to BMDM exposed to those forms of death that simultaneously released ATP and the DAMPs heat-shock protein 90 (HSP90) and high-mobility group box-1 protein (HMGB1). These results demonstrate that the tissue microenvironment generated by dying cells may determine the subsequent immune response.
- Published
- 2016
16. 01.14 Novel mechanism mediated by the IL23/TH17 axis contributing to auto-immune arthritis
- Author
-
R Pfeifle, Stephan Blüml, Martin Herrmann, Stephan Culemann, Gerhard Krönke, Axel J. Hueber, Georg Schett, Tobias Rothe, Ulrike Harre, Hans Scherer, Natacha Ipseiz, and Falk Nimmerjahn
- Subjects
biology ,business.industry ,medicine.medical_treatment ,Autoantibody ,Arthritis ,Germinal center ,Inflammation ,medicine.disease_cause ,medicine.disease ,Immunoglobulin G ,Autoimmunity ,Cytokine ,Immunology ,medicine ,Interleukin 23 ,biology.protein ,medicine.symptom ,business - Abstract
Background Checkpoints and mechanisms regulating the onset of rheumatoid arthritis (RA) remain largely elusive. Apart from B cells and auto-antibodies, Th17 cells were shown to critically contribute to disease development. Mice lacking IL-23, a cytokine controlling the pathogenicity of Th17 cells, are completely protected against arthritis. Yet, the exact role of the IL-23/Th17 axis during this autoantibody-driven disease remain incompletely understood. Material and methods IL23A-/- mice and mice receiving an IL23 blocking antibody were analysed during active and passive arthritis models including collagen-induced arthritis (CIA), the K/BxN arthritis model, collagen-antibody induced arthritis (CAIA) and K/BxN-serum transfer arthritis. Both clinical, histological and immunological parameters of arthritis were assessed. IgG glycosylation was analysed using the MALDI-TOF technique. IgG activity was determined by measuring the cytokine release of immune-complex-stimulated myeloid cells. To study the crosstalk between B cells and Th17 cells, co-culture experiments were performed. Results Here we report, that the IL-23/Th17 axis did not directly contribute to auto-antibody induced inflammation within inflamed joints, but controlled the glycosylation profile and inflammatory activity of auto-antibodies during the prodromal phase of disease. Th17 cells were found to accumulate in germinal centres auf secondary lymphatic organs prior to onset of experimental arthritis, where they suppressed the expression of β-glactoside α2,6-sialyltransferase 1 (St6gal1) in differentiating plasmablasts. The consecutive change in the immunoglobulin G (IgG) glycosylation profile provoked a shift towards a pro-inflammatory autoantibody repertoire and triggered the inflammatory phase of arthritis. Plasmablasts of RA patients similarly displayed a decreased St6gal1 activity, while IgG from these individuals showed corresponding changes in its glycosylation profile as well as an increased inflammatory activity, suggesting that related pathways might contribute to onset and progression of autoantibody-mediated diseases in humans. Conclusion Our current findings identify a novel IL-23/Th17-dependent checkpoint that controls autoantibody activity, unmasks a preexisting breach in humoral tolerance, and initiates the transition from a stage of asymptomatic autoimmunity into inflammatory autoimmune disease.
- Published
- 2017
17. Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
- Author
-
Stephan Blüml, Tobias Rothe, Wolfgang Schuh, René E. M. Toes, Yoann Rombouts, Gerhard Krönke, Martin Herrmann, Patrick Daum, Iryna Magorivska, Erik Lönnblom, Axel J. Hueber, R Pfeifle, Kutty Selva Nandakumar, Martina Seefried, Gordon F. Heidkamp, Changrong Ge, Carolien A. M. Koeleman, Christoph Becker, Sybille Böhm, Stephan Culemann, Stefan Uderhardt, Rikard Holmdahl, Arnd Kleyer, Thomas Winkler, Benjamin Haugg, Georg Schett, Falk Nimmerjahn, Ulrike Harre, Anja Lux, Diana Dudziak, Hans Scherer, Jochen A. Ackermann, Manfred Wuhrer, and Natacha Ipseiz
- Subjects
0301 basic medicine ,Glycosylation ,Immunology ,Autoimmunity ,medicine.disease_cause ,Lymphocyte Activation ,Interleukin-23 ,Immunoglobulin G ,Article ,Arthritis, Rheumatoid ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,medicine ,Interleukin 23 ,Immune Tolerance ,Immunology and Allergy ,Animals ,Humans ,beta-D-Galactoside alpha 2-6-Sialyltransferase ,Cells, Cultured ,Autoantibodies ,Autoimmune disease ,B-Lymphocytes ,biology ,business.industry ,Interleukins ,Autoantibody ,Cell Differentiation ,medicine.disease ,Sialyltransferases ,3. Good health ,Mice, Inbred C57BL ,Disease Models, Animal ,030104 developmental biology ,chemistry ,Rheumatoid arthritis ,biology.protein ,Th17 Cells ,Antibody ,business ,Signal Transduction - Abstract
The checkpoints and mechanisms that contribute to autoantibody-driven disease are as yet incompletely understood. Here we identified the axis of interleukin 23 (IL-23) and the TH17 subset of helper T cells as a decisive factor that controlled the intrinsic inflammatory activity of autoantibodies and triggered the clinical onset of autoimmune arthritis. By instructing B cells in an IL-22- and IL-21-dependent manner, TH17 cells regulated the expression of β-galactoside α2,6-sialyltransferase 1 in newly differentiating antibody-producing cells and determined the glycosylation profile and activity of immunoglobulin G (IgG) produced by the plasma cells that subsequently emerged. Asymptomatic humans with rheumatoid arthritis (RA)-specific autoantibodies showed identical changes in the activity and glycosylation of autoreactive IgG antibodies before shifting to the inflammatory phase of RA; thus, our results identify an IL-23–TH17 cell–dependent pathway that controls autoantibody activity and unmasks a preexisting breach in immunotolerance.
- Published
- 2016
- Full Text
- View/download PDF
18. Glucocorticoids suppress inflammation in arthritis via the glucocorticoid receptor in non-hematopoietic cells
- Author
-
Mascha Koenen, Hong Zhou, Ulrike Baschant, Markus J. Seibel, Stephan Culemann, Lorenz C. Hofbauer, and Jan Tuckermann
- Subjects
Haematopoiesis ,Glucocorticoid receptor ,business.industry ,Cancer research ,Medicine ,Arthritis ,Inflammation ,General Medicine ,medicine.symptom ,business ,medicine.disease - Published
- 2014
19. Novel mechanisms of action and new target genes of the glucocorticoid receptor in inflammatory bone disease and bone loss
- Author
-
Hong Zhou, Stephan Culemann, Lorenz C. Hofbauer, Jeanette Knoll, Martina Rauner, Gehrhard Kronke, Jean-Pierre David, Stephanie Wittig-Blaich, Mascha Koenen, Kerstin Bauer, Alexander Rauch, Anne Dudeck, Sebastian Schauer, Markus J. Seibel, Jan Tuckermann, Mubashir Ahmad, Ulrike Baschant, and Aspasia Ploubidou
- Subjects
medicine.medical_specialty ,Endocrinology ,Glucocorticoid receptor ,Action (philosophy) ,business.industry ,Internal medicine ,medicine ,General Medicine ,Inflammatory bone disease ,business ,Gene - Published
- 2014
20. Molecular determinants of glucocorticoid actions in inflammatory joint diseases
- Author
-
Ulrike Baschant, Stephan Culemann, and Jan Tuckermann
- Subjects
medicine.medical_treatment ,T-Lymphocytes ,Osteoporosis ,Anti-Inflammatory Agents ,Arthritis ,Inflammation ,Biochemistry ,Bone and Bones ,Cell Physiological Phenomena ,Arthritis, Rheumatoid ,Endocrinology ,Glucocorticoid receptor ,Receptors, Glucocorticoid ,medicine ,Animals ,Humans ,Myeloid Cells ,Adverse effect ,Molecular Biology ,Glucocorticoids ,business.industry ,Immunosuppression ,medicine.disease ,Rheumatoid arthritis ,Immunology ,medicine.symptom ,business ,Glucocorticoid ,Joint Capsule ,medicine.drug - Abstract
Since their discovery in 1948, glucocorticoids have been widely used clinically to treat inflammatory disorders like rheumatoid arthritis. However, their usefulness, especially in rheumatoid arthritis therapy, is hampered by severe side effects on bone leading to glucocorticoid-induced osteoporosis. The molecular and cellular mechanisms mediating the beneficial and adverse effects remain poorly understood. Nevertheless, advanced molecular biological analyses and in vivo approaches using conditional mutant mice have helped to unravel in part the underlying mechanisms of immunosuppression and side effects of glucocorticoid therapy in arthritis, thereby contributing to an improved understanding of these therapeutically important hormones.
- Published
- 2013
21. IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation
- Author
-
Natacha Ipseiz, Gerhard Krönke, Jochen A. Ackermann, Philipp Kirchner, Roland Lang, Joerg Hofmann, Georg Schett, Stephan Culemann, David Voehringer, Meik Kunz, Maria Faas, Martin Böttcher, Arif B. Ekici, Fenja Schröder, Maximilian Fuchs, Stefan Wirtz, Dimitrios Mougiakakos, Alessandro Michelucci, Cornelia Stoll, Julio Vera, Tobias Rothe, Benno Weigmann, Stefan Uderhardt, Carina Scholtysek, Anika Grüneboom, and Martin Eberhardt
- Subjects
Immunology ,Medizin ,Respiratory chain ,Inflammation ,Biology ,parasitic diseases ,medicine ,Immunology and Allergy ,Macrophage ,Gene ,Transcription factor ,Phagocytes ,Macrophages ,GATA3 ,Cell Differentiation ,Macrophage Activation ,Interleukin-33 ,Mitochondria ,Cell biology ,Interleukin 33 ,Infectious Diseases ,medicine.symptom ,Energy Metabolism ,Reprogramming ,Biomarkers ,Signal Transduction - Abstract
Alternatively activated macrophages (AAMs) contribute to the resolution of inflammation and tissue repair. However, molecular pathways that govern their differentiation have remained incompletely understood. Here, we show that uncoupling protein-2-mediated mitochondrial reprogramming and the transcription factor GATA3 specifically controlled the differentiation of pro-resolving AAMs in response to the alarmin IL-33. In macrophages, IL-33 sequentially triggered early expression of pro-inflammatory genes and subsequent differentiation into AAMs. Global analysis of underlying signaling events revealed that IL-33 induced a rapid metabolic rewiring of macrophages that involved uncoupling of the respiratory chain and increased production of the metabolite itaconate, which subsequently triggered a GATA3-mediated AAM polarization. Conditional deletion of GATA3 in mononuclear phagocytes accordingly abrogated IL-33-induced differentiation of AAMs and tissue repair upon muscle injury. Our data thus identify an IL-4-independent and GATA3-dependent pathway in mononuclear phagocytes that results from mitochondrial rewiring and controls macrophage plasticity and the resolution of inflammation.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.